Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
Caterina Cascini, Claudia Chiodoni
Cells (2021) Vol. 10, Iss. 7, pp. 1668-1668
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
Mingyi Yang, Haishi Zheng, Ke Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 86
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways
He Pang, Tingrui Wu, Zhonghua Peng, et al.
Journal of bone oncology (2022) Vol. 33, pp. 100415-100415
Open Access | Times Cited: 43
Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells
Wenkai Chen, Zongguang Li, Naichun Yu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features
Honglin Zhu, Hui Luo, Brian Skaug, et al.
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 6, pp. 1251-1261.e13
Closed Access | Times Cited: 18
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations
Nojoud Al-Ansari, Samson Mathews Samuel, Dietrich Büsselberg
Biomolecules (2024) Vol. 14, Iss. 2, pp. 145-145
Open Access | Times Cited: 6
A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
Runsang Pan, Feng Pan, Zhirui Zeng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review
Dylan D. Thomas, Ryan A. Lacinski, Brock A. Lindsey
Journal of bone oncology (2023) Vol. 39, pp. 100475-100475
Open Access | Times Cited: 12
Clinical and translational implications of immunotherapy in sarcomas
Federica Recine, Silvia Vanni, Alberto Bongiovanni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
Andrew D.J. Pearson, Nathalie Gaspar, Katherine A. Janeway, et al.
European Journal of Cancer (2022) Vol. 173, pp. 71-90
Open Access | Times Cited: 18
Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
Yujian Zhong, Yubiao Zhang, Sixing Wei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
Caterina Cascini, Chiara Ratti, Laura Botti, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10
Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth
Carina Proença, Ana T. Rufino, Isabela Santos, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1744-1744
Open Access | Times Cited: 10
Integral invariant manifold method applied to a mathematical model of osteosarcoma
Ophir Nave
Results in Control and Optimization (2025), pp. 100529-100529
Open Access
Self-assembled injectable Icariin@ Ti3C2Tx/doxorubicin hydrogel preserving osteogenesis while synergizing photodynamic and chemodynamic therapy for osteosarcoma
Jiahao Fu, Hao Chen, Yiqiao Zhao, et al.
Journal of Materials Science Materials in Medicine (2025) Vol. 36, Iss. 1
Open Access
Myeloid Cells in the Immunosuppressive Microenvironment as Immunotargets in Osteosarcoma
Cyrus Sholevar, Natalie M Liu, Tasneem Mukarrama, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 247-258
Open Access
A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery
Susana Buendía-López, Alba Rubio‐San‐Simón, Jen-Hao Wu, et al.
Clinical & Translational Oncology (2025)
Closed Access
Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy
Aurélie Dutour, Michela Pasello, L J Farrow, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling
Jiaming Zhang, Wei Wang
Frontiers in Immunology (2025) Vol. 16
Open Access
HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth
Qicai Han, Penghui Yan, Ruipeng Song, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 9
Oral microbiota distinguishes patients with osteosarcoma from healthy controls
Yu Chen, Chao Li, Xin Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Development of a novel six DNA damage response-related prognostic signature in osteosarcoma
Tianyang Li, Zhenzhou Tang, Sucheng Li, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 3, pp. 110-115
Open Access | Times Cited: 2
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
Elham Sajjadi, Gabriella Gaudioso, Andrea Terrasi, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 10
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis
Н. М. Тодосенко, И. А. Хлусов, K. А. Yurova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8993-8993
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top